Society guideline links: Acute myeloid leukemia

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Myeloproliferative neoplasms".)

●(See "Society guideline links: Myelodysplastic syndromes".)

●(See "Society guideline links: Chronic myeloid leukemia".)

●(See "Society guideline links: Acute promyelocytic leukemia".)

International

●International Society on Thrombosis and Haemostasis (ISTH): Guidance for the management of hemostatic complications in acute leukemia (2020)

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of acute leukemia (2020)

Canada

●Ontario Health (OH) (Cancer Care Ontario [CCO]): Minimal residual disease testing in acute leukemia (2020)

●CCO: Systemic treatment of acute myeloid leukemia (AML) (2016)

●CCO: Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia (2012)

United States

●American Society for Transplantation and Cellular Therapy (ASTCT): An evidence-based review on hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia (2021)

●American Society of Hematology (ASH): Guidelines for treating newly diagnosed acute myeloid leukemia in older adults (2020)

●American Society of Clinical Oncology (ASCO): Clinical practice guideline endorsement of the College of American Pathologists (CAP) and ASH guideline on initial diagnostic work-up of acute leukemia (2018)

●CAP and ASH: Guideline on initial diagnostic workup of acute leukemia (2017)

Europe

●European LeukemiaNet (ELN): Recommendations from an international expert panel for the diagnosis and management of AML in adults (2022)

●ELN: A consensus document on MRD in acute myeloid leukemia, update (2021)

●ELN: Risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation (2021)

●European Society of Medical Oncology (ESMO): Acute myeloid leukaemia in adult patients – Clinical practice guidelines for diagnosis, treatment, and follow-up (2020)

●ELN: A consensus document on minimal/measurable residual disease in AML (2018)

●European Society for Blood and Marrow Transplantation (EBMT): A position statement on haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia (2017)

United Kingdom

●British Society for Haematology (BSH): A good practice paper for the management of older patients with frailty and acute myeloid leukaemia (2022)

●British Committee for Standards in Haematology (BCSH): Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy (2015)

Japan

●Japanese Society of Hematology (JSH): Guideline for tumors of hematopoietic and lymphoid tissues – Leukemia: 1. Acute myeloid leukemia (AML) (2017)